Oncorus competitorsClear all

Oncorus's top competitors include Italfarmaco, Achilles Therapeutics, Loxo Oncology and G1 Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Oncorus
Oncorus
Oncorus is a biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients.
Italfarmaco
Italfarmaco
Italfarmaco is a pharmaceutical company providing products in the cardiovascular, immuno-oncologic, and gynecological areas.
Achilles Therapeutics
Achilles Therapeutics
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
Loxo Oncology
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
G1 Therapeutics
G1 Therapeutics
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
Founding Date
Founding Date
2015
Founding Date
1938
Founding Date
2016
Founding Date
2013
Founding Date
2008
Type
Type
Public
Type
Private
Type
Private
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cinisello Balsamo, IT HQ
Paleo Faliro, GR
Milano, IT
Algés, PT
Moskva, RU
Alcobendas, ES
Berwyn, US
Locations
London, GB HQ
Stevenage, GB
Locations
Stamford, US HQ
Alcobendas, ES
Boulder, US
New York, US
South San Francisco, US
Locations
Durham, US HQ
Employees
Employees
514% decrease
Employees
3,043
Employees
153
Employees
4133% increase
Employees
12217% increase
Valuation ($)
Valuation ($)
263.1 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
530.2 m
Twitter followers
Twitter followers
386
Twitter followers
N/A
Twitter followers
345
Twitter followers
46
Twitter followers
1.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
11
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
321129
Alexa Website Rank
355629
Alexa Website Rank
333221
Alexa Website Rank
229097
Alexa Website Rank
214590
Employee Rating
Employee Rating
4.1
Employee Rating
3.2
Employee Rating
4
Employee Rating
5
Employee Rating
3

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$45.3m (FY, 2020)
Net income
Net income
($48.3m) (FY, 2020)
Net income
N/A
Net income
($33.2m) (FY, 2020)
Net income
($148.9m) (FY, 2017)
Net income
($99.3m) (FY, 2020)

Operating

Patents (US)
Patents (US)
15 (Q2, 2020)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
40 (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 141.5m
Total funding raised
N/A
Total funding raised
$ 138.1m
Total funding raised
$ 57m
Total funding raised
$ 289.6m
For sources of this data, please see the company profile

View company profiles

Italfarmaco
HQ
Cinisello Balsamo, IT
Employees
3,043

Italfarmaco is a pharmaceutical company providing products in the cardiovascular, immuno-oncologic, and gynecological areas.

View company
Achilles Therapeutics
HQ
London, GB
Employees
153

Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.

View company
Loxo Oncology
HQ
Stamford, US

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company
G1 Therapeutics
HQ
Durham, US
Employees
122↑ 17% increase

G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.

View company